AUA 2018: Studies Show Men with Orchialgia or Chronic Pelvic Pain Could Benefit from Multifaceted Therapies including Physical Therapy, Low Doses of Tadalafil and Dry Needling

Truckee, CA (UroToday.com) -- A multifaceted approach to treating men with orchialgia and chronic pelvic pain may lead to improvements in quality of life and less pain over time, according to data being presented at the 113th Annual Scientific Meeting of the American Urological Association (AUA). These studies will be presented to the media during a special press conference on Sunday, May 20 at 11:00 a.m. (PT) at the Moscone Center in San Francisco, CA. This session will be moderated by Jamin Brahmbhatt, MD, men’s health specialist and urologist with Orlando Health in Clermont, Florida.

AUA 2018: Research Connects Poor Sleep Quality and Nocturia with Erectile Dysfunction, Low Testosterone and Increased Risk of Death

Truckee, CA (UroToday.com) -- While nocturia and poor sleep quality have been linked to such daytime problems as difficulty concentrating, a general lack of energy and irritability or impulsive behaviors, three new studies presented at the 113th Annual Scientific Meeting of the American Urological Association (AUA) are proving poor sleep quality can lead to serious health risks. During a joint press conference at the Moscone Convention Center in San Francisco, CA, May 20 at 9:00 a.m. (PT), researchers will share data highlighting their association between poor sleep quality, nocturia, low testosterone, erectile function, elevated body mass index (BMI) and even death. This press session will be moderated by Tobias S. Köhler, MD, MPH, FACS, men’s health specialist and urologist with the Mayo Clinic in Rochester, MN.

AUA 2018: Women’s Health and Urinary Functions

Truckee, CA (UroToday.com) -- Panel discusses the impact of women’s health & fitness behaviors on urinary functions. Two studies examining the impact a therapeutic yoga program and proper toileting behaviors have on a woman’s urinary function will be presented at the 113th Annual Meeting of the American Urological Association (AUA) Sunday, May 20, at 8:00 a.m. (PT) in the San Francisco Moscone Convention Center. Meena Davuluri, MD, with the Montefiore Health System in New York, will moderate the session.

AUA 2018: Couples with Male Factor Infertility Potentially Being Treated Prior to Testing

Truckee, CA (UroToday.com) -- Many couples with male factor infertility are being treated with intrauterine insemination (IUI) or in vitro fertilization (IVF) prior to the men being tested for fertility issues, according to a new study at the 113th Annual Meeting of the American Urological Association (AUA). The study will be presented to the media during a special press conference on Saturday, May 19 at 11:30 a.m. PT at the Moscone Center in San Francisco, CA.

AUA 2018: Erectile Dysfunction in the Adult Entertainment Industry Similar to that of the General Adult Male Population

Truckee, CA (UroToday.com) -- New studies show promise in understanding more about erectile dysfunction - Erectile dysfunction (ED) affects 30 million men in the United States. Three new studies evaluating the prevalence of ED in certain populations, as well as ED treatments and their availability to patients, are being presented at the 113th Annual Scientific Meeting of the American Urological Association (AUA) in San Francisco, CA. The study will be presented to the media during a special press conference on Saturday, May 19 at 10:30 a.m. (PT) at the Moscone Convention Center. The session will be moderated by Tobias S. Köhler, MD, MPH, FACS, AUA spokesperson, men’s health specialist and urologist with the Mayo Clinic in Rochester, MN.

AUA 2018: New Research on Prostate Cancer Management Protocols and Treatments

Truckee, CA (UroToday.com) -- Researchers will present new findings on a Korean FDA approved robotic system, safety of testosterone therapy after prostate cancer and active surveillance protocol for low-risk prostate cancer patients at the 113th Annual Meeting of the American Urological Association on Saturday, May 19 at 9:30 a.m. (PT) at the Moscone Center in San Francisco, CA.  Scott Eggener, MD, AUA spokesperson and Director of the Prostate Cancer Program at the University of Chicago Medicine, will moderate the session.

AUA 2018: Use of Magnetic Resonance Imaging for Prostate Cancer Screening and Management

Truckee, CA (UroToday.com) -- Use of magnetic resonance imaging (MRI) in the diagnosis of prostate cancer is increasing, and brings added value to screening and surveillance, according to new studies being presented this year during the 113th Annual Meeting of the American Urological Association (AUA). Four studies highlighting the effectiveness of MRI in the diagnosis and management of prostate cancer will be presented during a special press conference on May 19 at 8:30 a.m. (PT). Stacy Loeb, MD, AUA spokesperson and assistant professor of urology and population health at New York University will moderate this session for media.
Page 1 of 3
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe